+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Non-invasive Glucose Monitoring Devices Market 2024-2028

  • PDF Icon

    Report

  • 158 Pages
  • November 2023
  • Region: Global
  • TechNavio
  • ID: 5264304
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The non-invasive glucose monitoring devices market is forecasted to grow by USD 25.98 million during 2023-2028, accelerating at a CAGR of 15.46% during the forecast period. The report on the non-invasive glucose monitoring devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of diabetes and initiatives by governments, frequent launch of non-invasive glucose monitoring devices, and increasing demand for non-invasive procedures.

The non-invasive glucose monitoring devices market is segmented as below:

By Product

  • Wearable
  • Non-wearable

By End-user

  • Home care settings
  • Hospitals
  • Clinics

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing focus on collaborations for business expansion as one of the prime reasons driving the non-invasive glucose monitoring devices market growth during the next few years. Also, integration of AI and radar technology in glucose monitoring and growing funding for non-invasive glucose monitoring technology will lead to sizable demand in the market.

The report on the non-invasive glucose monitoring devices market covers the following areas:

  • Non-invasive glucose monitoring devices market sizing
  • Non-invasive glucose monitoring devices market forecast
  • Non-invasive glucose monitoring devices market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading non-invasive glucose monitoring devices market vendors that include Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., Gluco Rx Ltd., Glucowise, F. Hoffmann La Roche Ltd., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc.. Also, the non-invasive glucose monitoring devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global non-invasive glucose monitoring devices market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global non-invasive glucose monitoring devices market 2018 - 2022 ($ million)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 End-user Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Wearable - Market size and forecast 2023-2028
Exhibit 34: Chart on Wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Wearable - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Wearable - Year-over-year growth 2023-2028 (%)
6.4 Non-wearable - Market size and forecast 2023-2028
Exhibit 38: Chart on Non-wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-wearable - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-wearable - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
7.2 Comparison by End-user
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
7.3 Home care settings - Market size and forecast 2023-2028
Exhibit 48: Chart on Home care settings - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Home care settings - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
7.4 Hospitals - Market size and forecast 2023-2028
Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.5 Clinics - Market size and forecast 2023-2028
Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by End-user
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 India - Market size and forecast 2023-2028
Exhibit 95: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on India - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
12.4 Ascensia Diabetes Care Holdings AG
Exhibit 116: Ascensia Diabetes Care Holdings AG - Overview
Exhibit 117: Ascensia Diabetes Care Holdings AG - Product / Service
Exhibit 118: Ascensia Diabetes Care Holdings AG - Key offerings
12.5 BoydSense SAS
Exhibit 119: BoydSense SAS - Overview
Exhibit 120: BoydSense SAS - Product / Service
Exhibit 121: BoydSense SAS - Key offerings
12.6 Cnoga
Exhibit 122: Cnoga - Overview
Exhibit 123: Cnoga - Product / Service
Exhibit 124: Cnoga - Key offerings
12.7 Dexcom Inc.
Exhibit 125: Dexcom Inc. - Overview
Exhibit 126: Dexcom Inc. - Product / Service
Exhibit 127: Dexcom Inc. - Key news
Exhibit 128: Dexcom Inc. - Key offerings
12.8 DiaMonTech AG
Exhibit 129: DiaMonTech AG - Overview
Exhibit 130: DiaMonTech AG - Product / Service
Exhibit 131: DiaMonTech AG - Key offerings
12.9 Gluco Rx Ltd.
Exhibit 132: Gluco Rx Ltd. - Overview
Exhibit 133: Gluco Rx Ltd. - Product / Service
Exhibit 134: Gluco Rx Ltd. - Key offerings
12.10 F. Hoffmann La Roche Ltd.
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
12.11 Medtronic Plc
Exhibit 140: Medtronic Plc - Overview
Exhibit 141: Medtronic Plc - Business segments
Exhibit 142: Medtronic Plc - Key news
Exhibit 143: Medtronic Plc - Key offerings
Exhibit 144: Medtronic Plc - Segment focus
12.12 Meta Materials Inc.
Exhibit 145: Meta Materials Inc. - Overview
Exhibit 146: Meta Materials Inc. - Product / Service
Exhibit 147: Meta Materials Inc. - Key offerings
12.13 Nemaura Medical Inc.
Exhibit 148: Nemaura Medical Inc. - Overview
Exhibit 149: Nemaura Medical Inc. - Product / Service
Exhibit 150: Nemaura Medical Inc. - Key offerings
12.14 Platinum Equity Advisors LLC
Exhibit 151: Platinum Equity Advisors LLC - Overview
Exhibit 152: Platinum Equity Advisors LLC - Product / Service
Exhibit 153: Platinum Equity Advisors LLC - Key offerings
12.15 Rite Aid Corp.
Exhibit 154: Rite Aid Corp. - Overview
Exhibit 155: Rite Aid Corp. - Business segments
Exhibit 156: Rite Aid Corp. - Key offerings
Exhibit 157: Rite Aid Corp. - Segment focus
12.16 Taiwan Biophotonic Co.
Exhibit 158: Taiwan Biophotonic Co. - Overview
Exhibit 159: Taiwan Biophotonic Co. - Product / Service
Exhibit 160: Taiwan Biophotonic Co. - Key offerings
12.17 Walgreens Boots Alliance Inc.
Exhibit 161: Walgreens Boots Alliance Inc. - Overview
Exhibit 162: Walgreens Boots Alliance Inc. - Business segments
Exhibit 163: Walgreens Boots Alliance Inc. - Key offerings
Exhibit 164: Walgreens Boots Alliance Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Product
Exhibit 6: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 18: Historic Market Size - Data Table on global non-invasive glucose monitoring devices market 2018 - 2022 ($ million)
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
Exhibit 34: Chart on Wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Wearable - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Wearable - Year-over-year growth 2023-2028 (%)
Exhibit 38: Chart on Non-wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Non-wearable - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Non-wearable - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Non-wearable - Year-over-year growth 2023-2028 (%)
Exhibit 42: Market opportunity by Product ($ million)
Exhibit 43: Data Table on Market opportunity by Product ($ million)
Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
Exhibit 46: Chart on Comparison by End-user
Exhibit 47: Data Table on Comparison by End-user
Exhibit 48: Chart on Home care settings - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Home care settings - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Home care settings - Year-over-year growth 2023-2028 (%)
Exhibit 52: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibit 56: Chart on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Clinics - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Clinics - Year-over-year growth 2023-2028 (%)
Exhibit 60: Market opportunity by End-user ($ million)
Exhibit 61: Data Table on Market opportunity by End-user ($ million)
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibit 95: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
Exhibit 107: Overview on factors of disruption
Exhibit 108: Impact of key risks on business
Exhibit 109: Vendors covered
Exhibit 110: Matrix on vendor position and classification
Exhibit 111: Abbott Laboratories - Overview
Exhibit 112: Abbott Laboratories - Business segments
Exhibit 113: Abbott Laboratories - Key news
Exhibit 114: Abbott Laboratories - Key offerings
Exhibit 115: Abbott Laboratories - Segment focus
Exhibit 116: Ascensia Diabetes Care Holdings AG - Overview
Exhibit 117: Ascensia Diabetes Care Holdings AG - Product / Service
Exhibit 118: Ascensia Diabetes Care Holdings AG - Key offerings
Exhibit 119: BoydSense SAS - Overview
Exhibit 120: BoydSense SAS - Product / Service
Exhibit 121: BoydSense SAS - Key offerings
Exhibit 122: Cnoga - Overview
Exhibit 123: Cnoga - Product / Service
Exhibit 124: Cnoga - Key offerings
Exhibit 125: Dexcom Inc. - Overview
Exhibit 126: Dexcom Inc. - Product / Service
Exhibit 127: Dexcom Inc. - Key news
Exhibit 128: Dexcom Inc. - Key offerings
Exhibit 129: DiaMonTech AG - Overview
Exhibit 130: DiaMonTech AG - Product / Service
Exhibit 131: DiaMonTech AG - Key offerings
Exhibit 132: Gluco Rx Ltd. - Overview
Exhibit 133: Gluco Rx Ltd. - Product / Service
Exhibit 134: Gluco Rx Ltd. - Key offerings
Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus
Exhibit 140: Medtronic Plc - Overview
Exhibit 141: Medtronic Plc - Business segments
Exhibit 142: Medtronic Plc - Key news
Exhibit 143: Medtronic Plc - Key offerings
Exhibit 144: Medtronic Plc - Segment focus
Exhibit 145: Meta Materials Inc. - Overview
Exhibit 146: Meta Materials Inc. - Product / Service
Exhibit 147: Meta Materials Inc. - Key offerings
Exhibit 148: Nemaura Medical Inc. - Overview
Exhibit 149: Nemaura Medical Inc. - Product / Service
Exhibit 150: Nemaura Medical Inc. - Key offerings
Exhibit 151: Platinum Equity Advisors LLC - Overview
Exhibit 152: Platinum Equity Advisors LLC - Product / Service
Exhibit 153: Platinum Equity Advisors LLC - Key offerings
Exhibit 154: Rite Aid Corp. - Overview
Exhibit 155: Rite Aid Corp. - Business segments
Exhibit 156: Rite Aid Corp. - Key offerings
Exhibit 157: Rite Aid Corp. - Segment focus
Exhibit 158: Taiwan Biophotonic Co. - Overview
Exhibit 159: Taiwan Biophotonic Co. - Product / Service
Exhibit 160: Taiwan Biophotonic Co. - Key offerings
Exhibit 161: Walgreens Boots Alliance Inc. - Overview
Exhibit 162: Walgreens Boots Alliance Inc. - Business segments
Exhibit 163: Walgreens Boots Alliance Inc. - Key offerings
Exhibit 164: Walgreens Boots Alliance Inc. - Segment focus
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
Exhibit 167: Currency conversion rates for US$
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
Exhibit 171: List of abbreviations

Executive Summary

The analyst recognizes the following companies as the key players in the global non-invasive glucose monitoring devices market: Abbott Laboratories, Ascensia Diabetes Care Holdings AG, BlueSemi, BoydSense SAS, Cnoga, Dexcom Inc., DiaMonTech AG, Eser Co., Gluco Rx Ltd., Glucowise, F. Hoffmann La Roche Ltd., Informed Data Systems Inc. and One Drop., Medtronic Plc, Meta Materials Inc., Nemaura Medical Inc., Platinum Equity Advisors LLC, Rite Aid Corp., Taiwan Biophotonic Co., Tandem Diabetes Care Inc., and Walgreens Boots Alliance Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing focus on collaborations for business expansion.'

According to the report, one of the major drivers for this market is the increasing prevalence of diabetes and initiatives by governments.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Ascensia Diabetes Care Holdings AG
  • BlueSemi
  • BoydSense SAS
  • Cnoga
  • Dexcom Inc.
  • DiaMonTech AG
  • Eser Co.
  • Gluco Rx Ltd.
  • Glucowise
  • F. Hoffmann La Roche Ltd.
  • Informed Data Systems Inc. and One Drop.
  • Medtronic Plc
  • Meta Materials Inc.
  • Nemaura Medical Inc.
  • Platinum Equity Advisors LLC
  • Rite Aid Corp.
  • Taiwan Biophotonic Co.
  • Tandem Diabetes Care Inc.
  • Walgreens Boots Alliance Inc.